KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Receivables: 2020-2025

Historic Change in Receivables for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$757,000.

  • Ginkgo Bioworks Holdings' Change in Receivables fell 115.14% to -$757,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 92.45%. This contributed to the annual value of $4.7 million for FY2024, which is 109.44% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Change in Receivables stood at -$757,000 for Q3 2025, which was up 82.32% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Change in Receivables registered a high of $85.4 million during Q4 2021, and its lowest value of -$59.1 million during Q3 2022.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Change in Receivables value was -$1.4 million (recorded in 2024), while the average stood at -$4.2 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Change in Receivables crashed by 533.87% in 2023 and then spiked by 1,187.07% in 2024.
  • Ginkgo Bioworks Holdings' Change in Receivables (Quarterly) stood at $85.4 million in 2021, then tumbled by 140.39% to -$34.5 million in 2022, then rose by 16.24% to -$28.9 million in 2023, then surged by 95.24% to -$1.4 million in 2024, then crashed by 115.14% to -$757,000 in 2025.
  • Its Change in Receivables stands at -$757,000 for Q3 2025, versus -$4.3 million for Q2 2025 and $4.7 million for Q1 2025.